Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 86

Results For "Post"

1357 News Found

Lupin launches Aptivate Champion Run for Kids
News | February 04, 2023

Lupin launches Aptivate Champion Run for Kids

Through this important initiative, Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in the Aptivate Champion Run


Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr
News | February 03, 2023

Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr

The company has posted net profit of Rs. 475.94 crores for the period ended December 31, 2022


Hester Biosciences Q3 FY23 consolidated net profit up at Rs. 11.18 Cr
News | February 02, 2023

Hester Biosciences Q3 FY23 consolidated net profit up at Rs. 11.18 Cr

The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022


Budget 2023-24: Industry welcomes focus on medical research and pharma innovation
Policy | February 02, 2023

Budget 2023-24: Industry welcomes focus on medical research and pharma innovation

It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047


Kokilaben Hospital launches Ortho Robot ‘Stryker Mako’
Medical Device | January 31, 2023

Kokilaben Hospital launches Ortho Robot ‘Stryker Mako’

The only robotic-arm assisted surgical device to conduct joint replacement with accuracy and better clinical outcomes


NIB is playing a vital role in ensuring that quality biological products reach the health system: Dr. Mandaviya
Policy | January 29, 2023

NIB is playing a vital role in ensuring that quality biological products reach the health system: Dr. Mandaviya

It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry


Vimta Labs reports Q3 FY23 consolidated PAT at Rs. 10.24 Cr
News | January 29, 2023

Vimta Labs reports Q3 FY23 consolidated PAT at Rs. 10.24 Cr

The company has reported total income of Rs. 78.50 crores during the period ended December 31, 2022


Aarti Drugs Q3 FY23 revenue grows 4%
News | January 28, 2023

Aarti Drugs Q3 FY23 revenue grows 4%

Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY


Dr. Reddys Laboratories Q3 FY2023 consolidated PAT up to Rs. 1243.9 Cr
News | January 27, 2023

Dr. Reddys Laboratories Q3 FY2023 consolidated PAT up to Rs. 1243.9 Cr

The company has reported total income of Rs. 6848.5 crores during the period ended December 31, 2022


Marengo Asia and Karkinos collaborate to cultivate comprehensive cancer care solutions in India
News | January 20, 2023

Marengo Asia and Karkinos collaborate to cultivate comprehensive cancer care solutions in India

The goal is to bring oncology therapy closer to the communities by integrating all services such as chemotherapy and radiation centers